Literature DB >> 31576340

Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution.

Federico Massa1, Riccardo Meli1, Silvia Morbelli2,3, Flavio Nobili1,2, Matteo Pardini1,2.   

Abstract

Entities:  

Year:  2019        PMID: 31576340      PMCID: PMC6685903          DOI: 10.21037/atm.2019.05.81

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  17 in total

Review 1.  The future of blood-based biomarkers for Alzheimer's disease.

Authors:  Kim Henriksen; Sid E O'Bryant; Harald Hampel; John Q Trojanowski; Thomas J Montine; Andreas Jeromin; Kaj Blennow; Anders Lönneborg; Tony Wyss-Coray; Holly Soares; Chantal Bazenet; Magnus Sjögren; William Hu; Simon Lovestone; Morten A Karsdal; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2013-07-11       Impact factor: 21.566

Review 2.  CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Bob Olsson; Ronald Lautner; Ulf Andreasson; Annika Öhrfelt; Erik Portelius; Maria Bjerke; Mikko Hölttä; Christoffer Rosén; Caroline Olsson; Gabrielle Strobel; Elizabeth Wu; Kelly Dakin; Max Petzold; Kaj Blennow; Henrik Zetterberg
Journal:  Lancet Neurol       Date:  2016-04-08       Impact factor: 44.182

3.  Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

Authors:  Mehtap Bacioglu; Luis F Maia; Oliver Preische; Juliane Schelle; Anja Apel; Stephan A Kaeser; Manuel Schweighauser; Timo Eninger; Marius Lambert; Andrea Pilotto; Derya R Shimshek; Ulf Neumann; Philipp J Kahle; Matthias Staufenbiel; Manuela Neumann; Walter Maetzler; Jens Kuhle; Mathias Jucker
Journal:  Neuron       Date:  2016-06-09       Impact factor: 17.173

4.  Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.

Authors:  Oliver Preische; Stephanie A Schultz; Anja Apel; Jens Kuhle; Stephan A Kaeser; Christian Barro; Susanne Gräber; Elke Kuder-Buletta; Christian LaFougere; Christoph Laske; Jonathan Vöglein; Johannes Levin; Colin L Masters; Ralph Martins; Peter R Schofield; Martin N Rossor; Neill R Graff-Radford; Stephen Salloway; Bernardino Ghetti; John M Ringman; James M Noble; Jasmeer Chhatwal; Alison M Goate; Tammie L S Benzinger; John C Morris; Randall J Bateman; Guoqiao Wang; Anne M Fagan; Eric M McDade; Brian A Gordon; Mathias Jucker
Journal:  Nat Med       Date:  2019-01-21       Impact factor: 53.440

Review 5.  Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.

Authors:  Frederic Brosseron; Marius Krauthausen; Markus Kummer; Michael T Heneka
Journal:  Mol Neurobiol       Date:  2014-02-25       Impact factor: 5.590

Review 6.  The Past and the Future of Alzheimer's Disease Fluid Biomarkers.

Authors:  Kaj Blennow; Henrik Zetterberg
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.

Authors:  Piotr Lewczuk; Natalia Ermann; Ulf Andreasson; Christian Schultheis; Jana Podhorna; Philipp Spitzer; Juan Manuel Maler; Johannes Kornhuber; Kaj Blennow; Henrik Zetterberg
Journal:  Alzheimers Res Ther       Date:  2018-07-28       Impact factor: 6.982

8.  Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.

Authors:  Jens Kuhle; Harald Kropshofer; Dieter A Haering; Uma Kundu; Rolf Meinert; Christian Barro; Frank Dahlke; Davorka Tomic; David Leppert; Ludwig Kappos
Journal:  Neurology       Date:  2019-02-08       Impact factor: 9.910

9.  sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.

Authors:  Marc Suárez-Calvet; Gernot Kleinberger; Miguel Ángel Araque Caballero; Matthias Brendel; Axel Rominger; Daniel Alcolea; Juan Fortea; Alberto Lleó; Rafael Blesa; Juan Domingo Gispert; Raquel Sánchez-Valle; Anna Antonell; Lorena Rami; José L Molinuevo; Frederic Brosseron; Andreas Traschütz; Michael T Heneka; Hanne Struyfs; Sebastiaan Engelborghs; Kristel Sleegers; Christine Van Broeckhoven; Henrik Zetterberg; Bengt Nellgård; Kaj Blennow; Alexander Crispin; Michael Ewers; Christian Haass
Journal:  EMBO Mol Med       Date:  2016-05-02       Impact factor: 12.137

10.  Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.

Authors:  Philip S J Weston; Teresa Poole; Natalie S Ryan; Akshay Nair; Yuying Liang; Kirsty Macpherson; Ronald Druyeh; Ian B Malone; R Laila Ahsan; Hugh Pemberton; Jana Klimova; Simon Mead; Kaj Blennow; Martin N Rossor; Jonathan M Schott; Henrik Zetterberg; Nick C Fox
Journal:  Neurology       Date:  2017-10-25       Impact factor: 9.910

View more
  5 in total

1.  Neurofilament light chain in the vitreous humor of the eye.

Authors:  Manju L Subramanian; Viha Vig; Jaeyoon Chung; Marissa G Fiorello; Weiming Xia; Henrik Zetterberg; Kaj Blennow; Madeleine Zetterberg; Farah Shareef; Nicole H Siegel; Steven Ness; Gyungah R Jun; Thor D Stein
Journal:  Alzheimers Res Ther       Date:  2020-09-17       Impact factor: 6.982

Review 2.  Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease.

Authors:  Linyu Wu; Xiaohui Xian; Guangyu Xu; Zixuan Tan; Fang Dong; Min Zhang; Feng Zhang
Journal:  Mediators Inflamm       Date:  2022-08-21       Impact factor: 4.529

Review 3.  The economic imperatives for technology enabled wellness centered healthcare.

Authors:  Graham B Jones; Justin M Wright
Journal:  J Public Health Policy       Date:  2022-08-03       Impact factor: 3.526

4.  Protective effects of curcumin against neuroinflammation induced by Aβ25-35 in primary rat microglia: modulation of high-mobility group box 1, toll-like receptor 4 and receptor for advanced glycation end products expression.

Authors:  Wei He; Kaiming Yuan; Bin Ji; Yuan Han; Jun Li
Journal:  Ann Transl Med       Date:  2020-02

5.  Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study.

Authors:  Sid O'Bryant; Melissa Petersen; James Hall; Leigh Johnson; Kristine Yaffe; Meredith Braskie; Arthur W Toga; Robert A Rissman
Journal:  Alzheimers Dement       Date:  2021-07-26       Impact factor: 16.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.